Segall Bryant & Hamill’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-209,196
| Closed | -$2.42M | – | 755 |
|
|
2021
Q4 | $2.42M | Buy |
209,196
+9,731
| +5% | +$112K | 0.02% | 392 |
|
|
2021
Q3 | $1.9M | Buy |
199,465
+5,300
| +3% | +$50.6K | 0.02% | 468 |
|
|
2021
Q2 | $1.87M | Buy |
194,165
+11,248
| +6% | +$108K | 0.02% | 460 |
|
|
2021
Q1 | $1.81M | Sell |
182,917
-2,616
| -1% | -$25.8K | 0.02% | 484 |
|
|
2020
Q4 | $4.28M | Sell |
185,533
-3,453
| -2% | -$79.7K | 0.05% | 317 |
|
|
2020
Q3 | $2.67M | Buy |
188,986
+137,233
| +265% | +$1.94M | 0.04% | 354 |
|
|
2020
Q2 | $781K | Buy |
51,753
+1,583
| +3% | +$23.9K | 0.01% | 488 |
|
|
2020
Q1 | $463K | Sell |
50,170
-5,607
| -10% | -$51.7K | 0.01% | 607 |
|
|
2019
Q4 | $543K | Sell |
55,777
-4,133
| -7% | -$40.2K | 0.01% | 642 |
|
|
2019
Q3 | $480K | Buy |
59,910
+249
| +0.4% | +$2K | 0.01% | 656 |
|
|
2019
Q2 | $744K | Buy |
59,661
+247
| +0.4% | +$3.08K | 0.01% | 594 |
|
|
2019
Q1 | $808K | Buy |
59,414
+1,588
| +3% | +$21.6K | 0.01% | 578 |
|
|
2018
Q4 | $554K | Buy |
57,826
+15,801
| +38% | +$151K | 0.01% | 632 |
|
|
2018
Q3 | $508K | Sell |
42,025
-34
| -0.1% | -$411 | 0.01% | 675 |
|
|
2018
Q2 | $657K | Buy |
+42,059
| New | +$657K | 0.01% | 619 |
|